J. Krain et Kp. Dieckmann, TREATMENT OF TESTICULAR SEMINOMA IN PATIENTS WITH HIV-INFECTION - REPORT OF 2 CASES, European urology, 26(2), 1994, pp. 184-186
The problem of adequate management of testicular germ cell tumors in p
atients with AIDS is increasingly important, as reflected by the incre
asing number of reports on the unclear pathogenetic association of the
two conditions. Two HIV-positive patients (32 and 39 years old) at CD
C stages II and IIb with pure seminoma have been treated. Both patient
s initially underwent semicastration. One patient (tumor stage IIa) th
en had retroperitoneal radiotherapy, and the other (tumor stage IIc) f
our cycles of carboplatin therapy. They have had no relapse after 35 a
nd 14 months, respectively, and there has been no progression in the H
IV infection stage. Stage-oriented treatment for testicular germ-cell
tumors can, in principle, be applied in patients with HIV infection. R
adiotherapy and chemotherapy do not necessarily lead to a deterioratio
n in the clinical state of health of the immune status of HIV-infected
patients and carboplatin monotherapy is an effective treatment with f
ew side effects in patients with metastatic seminoma.